Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience Announces $CA25 Million R&D Project with $CA7.3 Million Government Funding

NEW YORK, Dec. 3 (GenomeWeb News) - Tm Bioscience has announced a $CA25 million ($19.2 million) R&D project to develop genetic tests, which will be supported by a $CA7.3 million investment from an arm of the Canadian government, Technology Partnerships Canada.


The project, according to Tm, will include construction of a pilot manufacturing facility and development of five genetic tests that will meet regulatory standards, by a target date oin 2006.


Under the deal, Tm of Toronto said it will pay TPC a royalty on revenue from the products, and will issue TPC $CA2.5 million in five-year common share purchase warrants on Dec. 31, 2005, subject to regulatory approval.


Tm currently markets a P450-2D6 test and a CFTR40 test based on its Tag-It 100 analyte microarray technology. The company also says it is developing drug metabolism gene tests for the P450-2C9 and P450-2C19 genes, and a test panel for common hereditary disease genes.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.